Brief: Black Diamond Therapeutics Says BDTX-1535 Generally Well Tolerated, Consistent With Prior Disclosures And No New Safety Signals Observed
13/12/2023 12:26
Dec 13 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS INC: BDTX-1535 GENERALLY WELL
TOLERATED, CONSISTENT WITH PRIOR DISCLOSURES AND NO NEW SAFETY
SIGNALS OBSERVED
Source text for Eikon: ID:nGNX4YHy6D
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))